← Evidence map

ArticleJournal of clinical medicine2024

Real-World Experience with Brolucizumab Compared to Aflibercept in Treatment-Naïve and Therapy-Refractory Patients with Diabetic Macular Edema.

Anne Rübsam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38542043